Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis

BACKGROUND: Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine the differential effect of ezetimibe on MACEs when added to statins according to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Namki, Lee, Yong-ho, Tsujita, Kenichi, Gonzalez, Jorge A., Kramer, Christopher M., Kovarnik, Tomas, Kouvelos, George N., Suzuki, Hiromichi, Han, Kyungdo, Lee, Chan Joo, Park, Sung Ha, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021322/
https://www.ncbi.nlm.nih.gov/pubmed/29766679
http://dx.doi.org/10.3803/EnM.2018.33.2.219

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021322/
https://www.ncbi.nlm.nih.gov/pubmed/29766679
http://dx.doi.org/10.3803/EnM.2018.33.2.219

Ejemplares similares